Related Experiment Video

Updated: Aug 7, 2026

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients

N Katakami1, H Kaneto, M Matsuhisa

  • 1Department of Internal Medicine and Therapeutics (A8), Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan. katakami@medone.med.osaka-u.ac.jp

Diabetologia
|June 6, 2006
PubMed

Insights

Type 1 diabetes patients show higher soluble CD40 ligand (sCD40L) levels, a marker linked to cardiovascular events. These elevated sCD40L levels are associated with increased carotid atherosclerosis in young diabetic individuals.

Area of Science:

  • Cardiovascular Research
  • Endocrinology
  • Immunology

Background:

  • Soluble CD40 ligand (sCD40L) interacts with CD40 on vascular cells, promoting inflammation.
  • Elevated serum sCD40L levels are a known predictive marker for cardiovascular events.
  • Type 1 diabetes is associated with an increased risk of cardiovascular disease.

Purpose of the Study:

  • To measure serum sCD40L levels in type 1 diabetic patients.
  • To investigate the association between sCD40L levels and carotid atherosclerosis in type 1 diabetes.

Main Methods:

  • Serum sCD40L levels and carotid intima-media thickness (IMT) were measured in 80 type 1 diabetic patients and 20 healthy controls.
  • Statistical analyses, including multivariate regression, were used to assess associations.

Main Results:

  • Type 1 diabetic patients had significantly higher serum sCD40L levels compared to controls.
  • Patients with type 1 diabetes exhibited significantly greater Max-IMT and Mean-IMT.
  • sCD40L levels were significantly associated with both Max-IMT and Mean-IMT and independently predicted IMT.

Conclusions:

  • Increased serum sCD40L levels are linked to accelerated carotid atherosclerosis in young patients with type 1 diabetes.
  • sCD40L may play a role in the development of vascular complications in type 1 diabetes.
Abstract

More Related Videos

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...